Cargando…

Age-dependent neuroinflammation and cognitive decline in a novel Ala152Thr-Tau transgenic mouse model of PSP and AD

INTRODUCTION: Mutations of Tau are associated with several neurodegenerative disorders. Recently, the Tau mutation A152T was described as a novel risk factor for frontotemporal dementia spectrum disorders and Alzheimer disease. In vitro Tau-A152T shows a decreased binding to microtubules and a reduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Sydow, Astrid, Hochgräfe, Katja, Könen, Stefanie, Cadinu, Daniela, Matenia, Dorthe, Petrova, Olga, Joseph, Maria, Dennissen, Frank Johannes, Mandelkow, Eva-Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766625/
https://www.ncbi.nlm.nih.gov/pubmed/26916334
http://dx.doi.org/10.1186/s40478-016-0281-z
_version_ 1782417698380054528
author Sydow, Astrid
Hochgräfe, Katja
Könen, Stefanie
Cadinu, Daniela
Matenia, Dorthe
Petrova, Olga
Joseph, Maria
Dennissen, Frank Johannes
Mandelkow, Eva-Maria
author_facet Sydow, Astrid
Hochgräfe, Katja
Könen, Stefanie
Cadinu, Daniela
Matenia, Dorthe
Petrova, Olga
Joseph, Maria
Dennissen, Frank Johannes
Mandelkow, Eva-Maria
author_sort Sydow, Astrid
collection PubMed
description INTRODUCTION: Mutations of Tau are associated with several neurodegenerative disorders. Recently, the Tau mutation A152T was described as a novel risk factor for frontotemporal dementia spectrum disorders and Alzheimer disease. In vitro Tau-A152T shows a decreased binding to microtubules and a reduced tendency to form abnormal fibers. RESULTS: To study the effects of this mutation we generated a mouse model expressing human full-length Tau with this mutation (hTau40(AT)). At young age (2–3 months) immunohistological analysis reveals pathological Tau conformation and Tau-hyperphosphorylation combined with Tau missorting into the somatodendritic compartment of neurons. With increasing age there is Tau aggregation including co-aggregates of endogenous mouse Tau and exogenous human Tau, accompanied by loss of synapses (especially presynaptic failure) and neurons. From ~10 months onwards the mice show a prominent neuroinflammatory response as judged by activation of microglia and astrocytes. This progressive neuroinflammation becomes visible by in vivo bioluminescence imaging after crossbreeding of hTau40(AT) mice and Gfap-luciferase reporter mice. In contrast to other Tau-transgenic models and Alzheimer disease patients with reduced protein clearance, hTau40(AT) mice show a strong induction of autophagy. Although Tau-hyperphosphorylation and aggregation is also present in spinal cord and motor cortex (due to the Thy1.2 promoter), neuromotor performance is not affected. Deficits in spatial reference memory are manifest at ~16 months and are accompanied by neuronal death. CONCLUSIONS: The hTau40(AT) mice mimic pathological hallmarks of tauopathies including a cognitive phenotype combined with pronounced neuroinflammation visible by bioluminescence. Thus the mice are suitable for mechanistic studies of Tau induced toxicity and in vivo validation of neuroprotective compounds. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40478-016-0281-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4766625
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47666252016-02-26 Age-dependent neuroinflammation and cognitive decline in a novel Ala152Thr-Tau transgenic mouse model of PSP and AD Sydow, Astrid Hochgräfe, Katja Könen, Stefanie Cadinu, Daniela Matenia, Dorthe Petrova, Olga Joseph, Maria Dennissen, Frank Johannes Mandelkow, Eva-Maria Acta Neuropathol Commun Research INTRODUCTION: Mutations of Tau are associated with several neurodegenerative disorders. Recently, the Tau mutation A152T was described as a novel risk factor for frontotemporal dementia spectrum disorders and Alzheimer disease. In vitro Tau-A152T shows a decreased binding to microtubules and a reduced tendency to form abnormal fibers. RESULTS: To study the effects of this mutation we generated a mouse model expressing human full-length Tau with this mutation (hTau40(AT)). At young age (2–3 months) immunohistological analysis reveals pathological Tau conformation and Tau-hyperphosphorylation combined with Tau missorting into the somatodendritic compartment of neurons. With increasing age there is Tau aggregation including co-aggregates of endogenous mouse Tau and exogenous human Tau, accompanied by loss of synapses (especially presynaptic failure) and neurons. From ~10 months onwards the mice show a prominent neuroinflammatory response as judged by activation of microglia and astrocytes. This progressive neuroinflammation becomes visible by in vivo bioluminescence imaging after crossbreeding of hTau40(AT) mice and Gfap-luciferase reporter mice. In contrast to other Tau-transgenic models and Alzheimer disease patients with reduced protein clearance, hTau40(AT) mice show a strong induction of autophagy. Although Tau-hyperphosphorylation and aggregation is also present in spinal cord and motor cortex (due to the Thy1.2 promoter), neuromotor performance is not affected. Deficits in spatial reference memory are manifest at ~16 months and are accompanied by neuronal death. CONCLUSIONS: The hTau40(AT) mice mimic pathological hallmarks of tauopathies including a cognitive phenotype combined with pronounced neuroinflammation visible by bioluminescence. Thus the mice are suitable for mechanistic studies of Tau induced toxicity and in vivo validation of neuroprotective compounds. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40478-016-0281-z) contains supplementary material, which is available to authorized users. BioMed Central 2016-02-25 /pmc/articles/PMC4766625/ /pubmed/26916334 http://dx.doi.org/10.1186/s40478-016-0281-z Text en © Sydow et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Sydow, Astrid
Hochgräfe, Katja
Könen, Stefanie
Cadinu, Daniela
Matenia, Dorthe
Petrova, Olga
Joseph, Maria
Dennissen, Frank Johannes
Mandelkow, Eva-Maria
Age-dependent neuroinflammation and cognitive decline in a novel Ala152Thr-Tau transgenic mouse model of PSP and AD
title Age-dependent neuroinflammation and cognitive decline in a novel Ala152Thr-Tau transgenic mouse model of PSP and AD
title_full Age-dependent neuroinflammation and cognitive decline in a novel Ala152Thr-Tau transgenic mouse model of PSP and AD
title_fullStr Age-dependent neuroinflammation and cognitive decline in a novel Ala152Thr-Tau transgenic mouse model of PSP and AD
title_full_unstemmed Age-dependent neuroinflammation and cognitive decline in a novel Ala152Thr-Tau transgenic mouse model of PSP and AD
title_short Age-dependent neuroinflammation and cognitive decline in a novel Ala152Thr-Tau transgenic mouse model of PSP and AD
title_sort age-dependent neuroinflammation and cognitive decline in a novel ala152thr-tau transgenic mouse model of psp and ad
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766625/
https://www.ncbi.nlm.nih.gov/pubmed/26916334
http://dx.doi.org/10.1186/s40478-016-0281-z
work_keys_str_mv AT sydowastrid agedependentneuroinflammationandcognitivedeclineinanovelala152thrtautransgenicmousemodelofpspandad
AT hochgrafekatja agedependentneuroinflammationandcognitivedeclineinanovelala152thrtautransgenicmousemodelofpspandad
AT konenstefanie agedependentneuroinflammationandcognitivedeclineinanovelala152thrtautransgenicmousemodelofpspandad
AT cadinudaniela agedependentneuroinflammationandcognitivedeclineinanovelala152thrtautransgenicmousemodelofpspandad
AT mateniadorthe agedependentneuroinflammationandcognitivedeclineinanovelala152thrtautransgenicmousemodelofpspandad
AT petrovaolga agedependentneuroinflammationandcognitivedeclineinanovelala152thrtautransgenicmousemodelofpspandad
AT josephmaria agedependentneuroinflammationandcognitivedeclineinanovelala152thrtautransgenicmousemodelofpspandad
AT dennissenfrankjohannes agedependentneuroinflammationandcognitivedeclineinanovelala152thrtautransgenicmousemodelofpspandad
AT mandelkowevamaria agedependentneuroinflammationandcognitivedeclineinanovelala152thrtautransgenicmousemodelofpspandad